(S (NP-SBJ-36 (VBG Transforming) (NN growth) (NN factor-beta)) (VP (VBZ suppresses) (NP (JJ human) (NN B) (NN lymphocyte) (NN Ig) (NN production)) (PP (IN by) (S (NP-SBJ (-NONE- *-36)) (VP (VBG inhibiting) (NP-COOD (NP (NN synthesis)) (CC and) (NP (NP (DT the) (NN switch)) (PP (IN from) (NP (NP (DT the) (NN membrane) (NN form)) (PP (-NONE- *RNR*-37)))) (PP (TO to) (NP (NP (DT the) (JJ secreted) (NN form)) (PP (-NONE- *RNR*-37)))) (PP-37 (IN of) (NN Ig) (NN mRNA)))))))) (. .))
(S (NP-SBJ (NP (VBG Transforming) (NN growth) (NN factor-beta)) (PRN (-LRB- -LRB-) (NP (NN TGF-beta)) (-RRB- -RRB-))) (VP-COOD (VP (VBZ inhibits) (NP (NN B) (NN cell) (NN Ig) (NN secretion))) (CC and) (VP (VBZ reduces) (NP (NN B) (NN cell) (NN membrane) (NN Ig) (NN expression)))) (. .))
(S (NP-SBJ (NP (DT The) (NN addition)) (PP (IN of) (NP (NN TGF-beta))) (PP (TO to) (NP (NP (JJ human) (NN B) (NN lymphocyte) (NNS cultures)) (VP (VBN stimulated) (NP (-NONE- *)) (PP (IN with) (NP-COOD (NP (FW Staphylococcus) (FW aureus) (NN Cowan) (NN strain) (NN I)) (CC and) (NP (NN IL-2)))))))) (ADVP (RB completely)) (VP-COOD (VP (VP (VBD inhibited) (NP (NN B) (NN cell) (NN Ig) (NN secretion))) (PRN (-LRB- -LRB-) (FRAG (ADVP (ADVP (JJR greater)) (PP (IN than) (NP (CD 90) (NN %))))) (-RRB- -RRB-))) (CC and) (VP (VBD decreased) (NP (NN B) (NN cell) (NN surface) (NP-COOD (NP (NN IgM)) (, ,) (NP (NN IgD)) (, ,) (NP (NN kappa) (NN L) (NN chain)) (, ,) (CC and) (NP (NN lambda) (NN L) (NN chain))) (NN expression)))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NN TGF-beta)) (VP (VBD had) (NP (ADJP (RB only) (JJ minimal)) (NNS effects)) (PP (IN on) (NP (NP (CD two) (JJ other) (NN B) (NN cell) (NN membrane) (NNS proteins)) (, ,) (NP-COOD (NP (NN HLA-DR)) (CC and) (NP (NN CD20)))))) (. .))
(S (NP-SBJ-COOD (NP (NP (JJ Internal) (NN labeling)) (PP (IN with) (NP (NN -LCB-35S-RCB-methionine)))) (CC and) (NP (NP (NN immunoprecipitation)) (PP (IN with) (NP (ADJP-COOD (ADJP (JJ anti-IgM)) (, ,) (ADJP (JJ anti-kappa)) (, ,) (CC and) (ADJP (JJ anti-lambda))) (NNS antibodies))))) (VP (VBD revealed) (NP (NP (NP (DT a) (JJ striking) (NN reduction)) (PP (IN in) (NP (NN kappa) (NN L) (NN chain))) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN TGF-beta)))))) (. .))
(S (NP-SBJ-38 (NP (DT A) (ADJP (RBR less) (JJ pronounced)) (NN reduction)) (PP (IN in) (NP-COOD (NP (NN lambda) (NN L) (NN chain)) (CC and) (NP (NN microH) (NN chain))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN noted) (NP (-NONE- *-38)))) (. .))
(S (NP-SBJ (NP (NN Northern) (NN blot) (NN analysis)) (PP (IN of) (NP (NP (NN RNA)) (VP (VBN purified) (NP (-NONE- *)) (PP (IN from) (NP (NP (NN B) (NNS cells)) (VP (VBN treated) (NP (-NONE- *)) (PP (IN with) (NP (NN TGF-beta))) (PP-TMP (IN for) (NP (VBG varying) (NN time) (NNS intervals)))))))))) (VP (VBD revealed) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (JJ steady) (NN state) (NN kappa) (CC and) (NN lambda) (NN L) (NN chain) (NN mRNA) (NNS levels))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-39 (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN switch)) (PP (IN from) (NP (NP (DT the) (NN membrane) (NNS forms)) (PP (IN of) (NP-COOD (NP (NN mu)) (CC and) (NP (NN gamma)))))) (PP (TO to) (NP (PRP$ their) (JJ respective) (JJ secreted) (NNS forms)))))) (VP (VBD was) (VP (VBN noted) (NP (-NONE- *-39)) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN TGF-beta))))) (. .))
(S (NP-SBJ (JJ Nuclear) (JJ run-on) (NNS experiments)) (VP (VBD demonstrated) (NP (NP (VBN decreased) (NN transcription)) (PP (IN of) (NP (NN kappa) (NN L) (NN chain))))) (. .))
(S (NP-SBJ-40 (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN TGF-beta))) (PP (IN on) (NP (NP (NP (CD two) (JJ transcriptional) (JJ regulatory) (NNS factors)) (, ,) (NP-COOD (NP (NN Oct-2)) (CC and) (NP (NP (NP (JJ nuclear) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN NF)) (-RRB- -RRB-))) (NN kappa) (NN B))) (, ,)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ important) (PP (IN in) (NP (NN Ig) (NN gene) (NN transcription))))))))))) (VP (VBD were) (VP (VBN examined) (NP (-NONE- *-40)))) (. .))
(S (NP-SBJ-41 (NP-COOD (NP (NN Oct-2) (NN mRNA) (NNS levels)) (CC and) (NP (NP-COOD (DT both) (NP (NN Oct-2)) (CC and) (NP (NN NF-kappa) (NN B))) (NNS proteins))) (PP (IN in) (NP (JJ nuclear) (NNS extracts)))) (VP (VBD were) (RB not) (VP (VBN altered) (NP (-NONE- *-41)) (PP (IN by) (NP-LGS (NP (NN treatment)) (PP (IN with) (NP (NN TGF-beta))))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-42 (NP (NNS levels)) (PP (IN of) (NP (NP (DT the) (JJ transcriptional) (NN factor) (NN AP-1)) (, ,) (SBAR (WHNP-43 (WDT which)) (S (NP-SBJ-44 (-NONE- *T*-43)) (VP (VBZ is) (RB not) (VP (VBN known) (S (NP-SBJ (-NONE- *-44)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ important) (PP (IN in) (NP (NN B) (NN cell) (NN Ig) (NN production))))))))))) (, ,)))) (VP (VBD were) (VP (VBN reduced) (NP (-NONE- *-42)) (PP (IN by) (NP-LGS (NN TGF-beta))))) (. .))
(S (NP-SBJ (DT These) (NNS findings)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ-45 (NN TGF-beta)) (VP (VBZ decreases) (NP (NN B) (NN lymphocyte) (NN Ig) (NN secretion)) (PP (IN by) (S-NOM (NP-SBJ (-NONE- *-45)) (VP-COOD (VP (VBG inhibiting) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NN Ig) (NN mRNA))))) (CC and) (VP (VBG inhibiting) (NP (NP (DT the) (NN switch)) (PP (IN from) (NP (DT the) (NN membrane) (NN form))) (PP (TO to) (NP (NP (DT the) (JJ secreted) (NNS forms)) (PP (IN of) (NP (NP-COOD (NP (NN mu)) (CC and) (NP (NN gamma))) (NN mRNA)))))))))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN mechanism)) (SBAR (WHPP-46 (IN by) (WHNP (WDT which))) (S (NP-SBJ (NN TGF-beta)) (VP (VBZ inhibits) (NP (NN Ig) (NN chain) (NN synthesis)) (PP (-NONE- *T*-46)))))) (VP (VBZ is) (ADJP-PRD (JJ unclear)) (SBAR (IN although) (S (NP-SBJ (PRP it)) (VP (VBZ does) (RB not) (VP (VB involve) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP-COOD (NP (NN NF-kappa) (NN B)) (CC or) (NP (NN Oct-2)))) (PP (TO to) (NP (PRP$ their) (JJ respective) (NN target) (NNS sequences))))))))))) (. .))
